Skip to main content
Figure 1 | Critical Care

Figure 1

From: Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment

Figure 1

Presepsin (top), procalcitonin (PCT, middle) and IL-6 plasma levels (bottom) in patients admitted to the internal ICU with proven criteria of systemic inflammatory response syndrome (SIRS), sepsis, severe sepsis and septic shock. Left diagrams show results of biomarker measurements at day 1, middle diagrams show results at day 3 and right diagrams show results at day 8. Sixty individuals served as a control group at day 1. Data are presented as medians with 25th and 75th percentiles (boxes) and 5th and 95th percentiles (whiskers).

Back to article page

Critical Care

ISSN: 1364-8535